# Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer

> **NCT01296139** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 21 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Ferumoxytol

## Key facts

- **NCT ID:** NCT01296139
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-26
- **Primary completion:** 2015-03-19
- **Final completion:** 2015-03-19
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01296139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01296139, "Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01296139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*